Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication February 8, 2018
- Accepted for publication May 23, 2018
- Published online January 2, 2019.
Article Versions
- previous version (May 31, 2018 - 15:30).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Xiaowei Ma*,1,2,
- Shengjun Wang*,1,
- Shuailiang Wang1,
- Daliang Liu1,
- Xiaohu Zhao1,
- Hao Chen2,
- Fei Kang1,
- Weidong Yang1,
- Jing Wang1 and
- Zhen Cheng2
- 1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China; and
- 2Molecular Imaging Program at Stanford (MIPS), Bio-X Program, and Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, Stanford, California
- For correspondence or reprints contact either of the following Zhen Cheng, Molecular Imaging Program at Stanford, Canary Center at Stanford for Cancer Early Detection, Department of Radiology and Bio-X Program, Stanford University, 1201 Welch Rd., Lucas Expansion, P095, Stanford, CA 94305. E-mail: zcheng{at}stanford.edu
- Jing Wang, Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. E-mail: wangjing{at}fmmu.edu.cn
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future
- 18F-PFPN PET: A New and Attractive Imaging Modality for Patients with Malignant Melanoma
- Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy
- Ultrasensitive detection of malignant melanoma using PET molecular imaging probes
- N-(2-(Dimethylamino)Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma